Our Team
Our team comprises of accomplished scientist-entrepreneurs with novel foresight to imagine innovative solutions and products.
About 'CHRIS'
Chris Anderson, MBA, PMP
Christopher Anderson, MBA, is the VP of Program and Alliance Management at Cell BioEngines. With over 15 years of comprehensive BioPharma experience, Chris has cultivated a distinguished career marked by transformative leadership in healthcare and other sectors. His abilities span from strategic business analysis and portfolio planning to
Christopher Anderson, MBA, is the VP of Program and Alliance Management at Cell BioEngines. With over 15 years of comprehensive BioPharma experience, Chris has cultivated a distinguished career marked by transformative leadership in healthcare and other sectors. His abilities span from strategic business analysis and portfolio planning to proficient program leadership, covering the product development spectrum from research to commercialization.
Chris's career in BioPharma began at Novartis Pharma AG (NYSE: NVS) in Switzerland, where he laid the foundation for his future success. Since then, he has been instrumental in developing program management capabilities and steering innovative development programs across diverse therapeutic areas including Oncology, Rare Genetic Diseases, Neurology, and Ophthalmology. His program leadership has helped companies like Sarepta Therapeutics (NASDAQ: SRPT) and EyePoint Pharmaceuticals (NASDAQ: EYPT) to grow.
A graduate of Kennesaw State University, Chris earned his MBA with a concentration in strategic analysis and planning. Chris occasionally mentors for MIT Hacking Medicine, reflecting his commitment to fostering innovation and guiding the next generation of industry leaders.